Genetic Analysis AS (XSAT:GEAN)
Sweden · Delayed Price · Currency is SEK · Price in NOK 0.6700
-0.0400 (-5.63%)
At close: Aug 25, 2026
Genetic Analysis AS Cash Flow Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -11.43 | -11.41 | -14.77 | -23.82 | -28.27 | -29.01 |
Depreciation & Amortization | 1.63 | 1.73 | 1.64 | 2.13 | 1.38 | 1.35 |
Other Amortization | 3.44 | 3.44 | 3.6 | 3.45 | 3.45 | 3.19 |
Loss (Gain) on Equity Investments | - | - | 0.62 | 0.09 | - | - |
Stock-Based Compensation | 0.28 | 0.37 | 0.13 | 0.44 | 0.32 | 1.22 |
Other Operating Activities | -0.05 | 0 | -0.06 | 0.03 | 0.01 | 0.05 |
Change in Accounts Receivable | 0.2 | 1.29 | -1.3 | 0.71 | -1.56 | -0.19 |
Change in Inventory | -0.52 | -0.04 | 0.78 | 0.22 | 0.61 | -0.48 |
Change in Accounts Payable | -2.5 | -2.12 | -0.91 | 0.97 | 2.2 | 0.68 |
Change in Other Net Operating Assets | 7.89 | 9.14 | -1.36 | -1.45 | 2.4 | -4.42 |
Operating Cash Flow | -1.05 | 2.4 | -11.62 | -17.23 | -19.46 | -27.62 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.35 | -0.35 | -0.46 | -0.14 | -0.23 | -0.08 |
Sale (Purchase) of Intangibles | -6.07 | -5.18 | -1.49 | -0.5 | - | -1.87 |
Investment in Securities | - | - | -0.1 | -0.5 | - | - |
Investing Cash Flow | -6.42 | -5.54 | -2.05 | -1.14 | -0.23 | -1.95 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | 4.4 | - | - | - |
Long-Term Debt Repaid | - | -1.83 | -1.91 | -1.89 | -1.8 | -1.06 |
Net Debt Issued (Repaid) | 1.18 | -1.83 | 2.49 | -1.89 | -1.8 | -1.06 |
Issuance of Common Stock | 16.95 | 16.95 | 8.55 | 13.62 | - | 60.33 |
Other Financing Activities | -1.32 | -1.32 | -0.29 | -2.39 | - | -7.08 |
Financing Cash Flow | 16.81 | 13.79 | 10.75 | 9.34 | -1.8 | 52.19 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Miscellaneous Cash Flow Adjustments | - | -0 | - | - | - | - |
Net Cash Flow | 9.33 | 10.66 | -2.92 | -9.03 | -21.49 | 22.62 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1.4 | 2.05 | -12.08 | -17.38 | -19.69 | -27.7 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -6.52% | 9.68% | -58.41% | -75.02% | -94.88% | -207.07% |
Free Cash Flow Per Share | -0.02 | 0.03 | -0.27 | -0.66 | -0.79 | -1.11 |
Levered Free Cash Flow | -3.16 | 1 | -5.57 | -9.49 | -9.39 | -18.96 |
Unlevered Free Cash Flow | -2.38 | 1.31 | -5.35 | -9.33 | -9.31 | -18.88 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Change in Working Capital | 5.07 | 8.27 | -2.79 | 0.45 | 3.65 | -4.42 |